Low Dose Naltrexone
Low Dose Naltrexone
- Format
- Capsule
- Spec
- 1.5 mg
- Sourcing
- FDA-registered 503A pharmacy
Research Summary
Mechanism & Physiological Role
At sub-therapeutic doses, naltrexone transiently blocks opioid receptors, prompting compensatory upregulation of endogenous endorphin production and modulating microglial signaling.
Clinical & Research Applications
Studied in the literature on autoimmune conditions, inflammatory pain, and fibromyalgia. Prescribing decisions are made by the treating practitioner.
Scientific Publications
Peer-Reviewed References
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment
Younger J, Parkitny L, McLain D
Clinical Rheumatology · 2014 · PMID: 24526250
All compounded formulations are prepared by a licensed 503A sterile compounding pharmacy partner. Compounds are available to NPI-verified licensed practitioners only, per individual patient prescriptions in accordance with applicable state and federal law. Compounded medications are not FDA-approved. Pricing available upon verified account approval.
Ready to add Low Dose Naltrexone to your protocol?
Compounded formulations are dispensed by our licensed 503A pharmacy partner OBPRx under a valid patient-specific prescription. Prefer a formal quote? Request formulation-specific pricing instead.